House vote expected on stem-cell policy
- Mar 31, 2005 - comment
The Republican leadership of the House of Representatives has promised a vote on legislation designed to liberalize President Bush’s policy on federal funding of embryonic stem cell research.
The news encouraged those seeking to expand federally funded embryonic research. Rep. Michael Castle, R.-Del., said he hopes the House will take up legislation similar to his bill, which would permit funds for research on stem cells extracted from leftover embryos stored at fertility clinics, Congressional Quarterly reported March 25.
Castle is lead sponsor of the Stem Cell Research Enhancement Act, H.R. 810. Sen. Arlen Specter, R.-Pa., is sponsoring a companion bill, S. 471, in the Senate.
With 181 cosponsors, the House measure could pass, Castle said. “We are at a majority or close to it,” he told CQ.
The development presents a challenge for foes of funding embryonic research. The Ethics & Religious Liberty Commission and other pro-life organizations oppose embryonic stem cell research because procuring such cells destroys embryos. If the legislation is not defeated in Congress, President Bush may veto it.
The President, who instituted his policy in 2001, ordered a ban on federal funding of stem cell research that destroys embryos. He permitted funds for research on embryonic stem cell lines already in existence at the time he announced the policy.
“President Bush implemented a policy that allows for the first time federal funding of embryonic stem cell research, and it does so in a way that does not cross an important moral line,” White House spokeswoman Christie Parell said, according to CQ. “His views remain the same.”
The House leadership has not committed itself to a specific bill or a time for debate and vote on the controversial issue, an aide told CQ.
Stem cells are the body’s master cells that can develop into other cells and tissues, building hope for the treatment of numerous afflictions. In addition to being extracted from embryos, the cells may be found in such non-embryonic sources as bone marrow, umbilical cord blood, fat and placentas.
While embryonic stem cell research has failed to produce any successful therapies in human beings, research on stem cells from non-embryonic sources has produced treatments for more than 40 ailments, including spinal cord injuries, rheumatoid arthritis, lupus, multiple sclerosis and Crohn’s disease.
You may express your opinion to your senators and representative by calling the Capitol switchboard at (202) 224-3121 and asking for their offices or by emailing them through the ERLC’s Web site.
Further Learning
Learn more about: Life, Stem-Cell Research, Citizenship, Legislation